Meril Diagnostics Private Limited — Diagnostic Exporter Profile
Indian Pharmaceutical Exporter · #3 for Diagnostic · $1.6M export value · DGFT Verified
Meril Diagnostics Private Limited is the #3 Indian exporter of Diagnostic with $1.6M in export value and 161 verified shipments. Meril Diagnostics Private Limited holds a 8.5% market share in Diagnostic exports across 33 countries. The company exports 3 pharmaceutical products worth $7.2M across 2 therapeutic categories.
Meril Diagnostics Private Limited — Diagnostic Export Profile: Buyers & Destinations
Where Does Meril Diagnostics Private Limited Export Diagnostic?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $350.0K | 7 | 51.3% |
| AFGHANISTAN | $65.8K | 5 | 9.6% |
| EGYPT | $42.5K | 8 | 6.2% |
| PERU | $40.1K | 7 | 5.9% |
| GAUTEMALA | $28.7K | 6 | 4.2% |
| NEPAL | $25.2K | 24 | 3.7% |
| UZBEKISTAN | $20.0K | 1 | 2.9% |
| NIGERIA | $19.7K | 4 | 2.9% |
| EL SALVADOR | $11.8K | 1 | 1.7% |
| SOMAALIA | $11.6K | 3 | 1.7% |
Meril Diagnostics Private Limited exports Diagnostic to 34 countries. The largest destination is SRI LANKA accounting for 51.3% of Meril Diagnostics Private Limited's Diagnostic shipments, followed by AFGHANISTAN (9.6%) and EGYPT (6.2%). These destinations reflect Meril Diagnostics Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Diagnostic from Meril Diagnostics Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STATE PHARMACEUTICALS CORPORATION O | SRI LANKA | $350.0K | 7 |
| NOOR SHIFA NOORI LTD | AFGHANISTAN | $51.3K | 3 |
| ROOT DIAGNOSTIC CO | EGYPT | $22.2K | 3 |
| ROOT DIAGNOSTIC | EGYPT | $20.4K | 5 |
| ALLIANCE MEDICO LLC | UZBEKISTAN | $20.0K | 1 |
| PULSECARE PVTLTD | NIGERIA | $19.7K | 4 |
| IMALAB EIRL | PERU | $12.3K | 2 |
| EDWARD ENRIQUE LOPEZ LUNA | EL SALVADOR | $11.8K | 1 |
| BIN ARAB MEDICAL COMPANY SARL | SOMAALIA | $10.2K | 2 |
| INTERNATIONAL BIOMEDICASOCIEDAD | PERU | $10.0K | 1 |
Meril Diagnostics Private Limited supplies Diagnostic to 63 buyers globally. The largest buyer is STATE PHARMACEUTICALS CORPORATION O (SRI LANKA), followed by NOOR SHIFA NOORI LTD (AFGHANISTAN) and ROOT DIAGNOSTIC CO (EGYPT). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Diagnostic Export Value and How Much Does Meril Diagnostics Private Limited Contribute?
India exported $16.6M worth of Diagnostic through 7,808 shipments from 99 suppliers to 123 countries, serving 818 buyers globally. Meril Diagnostics Private Limited contributes $1.6M to this total, accounting for 8.5% of India's Diagnostic exports. Meril Diagnostics Private Limited ships Diagnostic to 34 countries through 63 buyers.
What Is the Average Shipment Value for Meril Diagnostics Private Limited's Diagnostic Exports?
Meril Diagnostics Private Limited's average Diagnostic shipment value is $9.8K per consignment, based on 161 shipments totaling $1.6M. The largest destination is SRI LANKA (51.3% of Meril Diagnostics Private Limited's Diagnostic exports).
How Does Meril Diagnostics Private Limited Compare to Other Indian Diagnostic Exporters?
Meril Diagnostics Private Limited ranks #3 among 99 Indian Diagnostic exporters with a 8.5% market share. The top 3 exporters are ADVY CHEMICAL PRIVATE LIMITED ($6.9M), ARKRAY HEALTHCARE PRIVATE LIMITED ($3.2M), MERIL DIAGNOSTICS PRIVATE LIMITED ($1.6M). Meril Diagnostics Private Limited processed 161 shipments to 33 destination countries.
What Diagnostic Formulations Does Meril Diagnostics Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DIAGNOSTIC KITS MERISCREEN Dengue NS1 Ag | $350.0K | 7 |
| DIAGNOSTICS RE-AGENT-ANTI A B D COMBO PA | $23.6K | 5 |
| DIAGNOSTICS RE AGENT ELISA MERILISA HIV GEN 4 480 TESTS | $20.0K | 1 |
| Diagnostic Re Agents ANTI A B D COMBO PACK 3X10ml | $19.9K | 6 |
| Diagnostic Re-Agents - ANTI A B D COMBO PACK (3X10) | $18.2K | 1 |
| Diagnostic Re-Agents - ANTI A B D COMBO PACK (3X10) | $18.2K | 1 |
| DIAGNOSTIC ELISA RE-AGENTS - ANTI A B DCOMBO PACK (3X10ML) | $15.0K | 1 |
| DIAGNOSTICS ELISA RE AGENT-ANTI A B D COMBO PACK (3X10ML) | $13.6K | 2 |
| DIAGNOSTICS ELISA RE-AGENTS - ANTI A B D COMBO PACK (3X10ML) | $12.5K | 2 |
| DIAGNOSTIC RE-AGENTS - ANTI A B D COMBOPACK (3X10ML) | $12.0K | 3 |
Meril Diagnostics Private Limited exports 118 distinct Diagnostic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DIAGNOSTIC KITS MERISCREEN Dengue NS1 Ag with 7 shipments worth $350.0K.
How Does Meril Diagnostics Private Limited Compare to Nearest Diagnostic Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ADVY CHEMICAL PRIVATE LIMITED | $6.9M | 2,567 | 23 | $2.7K |
| 2 | ARKRAY HEALTHCARE PRIVATE LIMITED | $3.2M | 628 | 56 | $5.2K |
| 3 | MERIL DIAGNOSTICS PRIVATE LIMITED ★ | $1.6M | 161 | 33 | $9.8K |
| 5 | LAB-CARE DIAGNOSTICS (INDIA) PRIVATE LIMITED | $726.4K | 597 | 27 | $1.2K |
| 6 | MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED | $712.9K | 641 | 22 | $1.1K |
Meril Diagnostics Private Limited ranks #3 among 99 Indian Diagnostic exporters. Average shipment value of $9.8K compared to the market average of $167.4K. The closest competitors by value are ADVY CHEMICAL PRIVATE LIMITED and ARKRAY HEALTHCARE PRIVATE LIMITED.
Which Indian Ports Ship Diagnostic Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,794 | 35.8% |
| SAHAR AIR | 2,102 | 26.9% |
| Bombay Air | 736 | 9.4% |
| DELHI AIR | 466 | 6.0% |
| DELHI AIR CARGO ACC (INDEL4) | 338 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 180 | 2.3% |
| Bombay Air Cargo | 178 | 2.3% |
| Ahmedabad Air | 145 | 1.9% |
What Other Medical Devices & Diagnostics Products Does Meril Diagnostics Private Limited Export?
Meril Diagnostics Private Limited also exports these medical devices & diagnostics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Meril Diagnostics Private Limited's Diagnostic Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Meril Diagnostics. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route for Indian exports to Europe and the Americas. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, escalating shipping costs and potentially affecting profit margins. (sgeexport.com)
Conversely, the India-European Union Free Trade Agreement (FTA), concluded in January 2026, is poised to benefit Indian exporters. The agreement aims to eliminate tariffs on a range of products, including pharmaceuticals, thereby enhancing market access for companies like Meril. This development could offset some of the increased shipping costs and bolster Meril's competitiveness in the European market. (en.wikipedia.org)
Additionally, the U.S.-China trade tensions have prompted the United States to diversify its import sources, presenting an opportunity for Indian pharmaceutical companies to capture a larger share of the U.S. market. Meril's established presence and compliance with international quality standards position it well to leverage this shift in trade dynamics.
Meril Diagnostics Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Meril has demonstrated a commitment to quality by adhering to guidelines set forth by regulatory bodies such as the FDA, WHO, and EU GMP. However, in December 2025, the World Health Organization issued a Notice of Concern regarding certain in-vitro diagnostic products manufactured by Meril, leading to their delisting from the WHO Prequalification List. This development underscores the importance of continuous quality assurance and regulatory vigilance to maintain market credibility and access. (extranet.who.int)
About Meril Diagnostics Private Limited
Meril Diagnostics Private Limited exports 3 products worth $7.2M. Beyond Diagnostic, top products include Kit, Plasma. View the complete Meril Diagnostics Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diagnostic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diagnostic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Meril Diagnostics Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 161 individual customs records matching Meril Diagnostics Private Limited exporting Diagnostic, covering 118 formulations to 34 countries via 63 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 818+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diagnostic Export Data from Meril Diagnostics Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Meril Diagnostics Private Limited's Diagnostic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Meril Diagnostics Private Limited
Full Company Profile →
3 products · $7.2M total trade · 2 categories
Diagnostic Stats
Company Overview
Top Products by Meril Diagnostics Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Meril Diagnostics Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diagnostic. For current shipment-level data, contact TransData Nexus.